MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/jpgm.jpgm_1132_20

Медицинская библиотека · Journal of postgraduate medicine · 2022

Unusual severe gastritis and gastric ulcers caused by pembrolizumab.

Liu W T, Li Y F, Hsieh T Y

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

Pembrolizumab (an immune checkpoint inhibitor)-related gastritis and gastric ulcers are rare immune-related adverse events, which are insufficiently treated with proton pump inhibitors (PPIs) therapy alone, and usually require systemic steroid therapy and even other biological agents (such as infliximab) in severe cases. Here, we report a case of 49-years-old woman suffering from gastritis and gastric ulcers after pembrolizumab treatment, which was refractory to 2 months of PPI therapy. The diagnosis was made by the clinical and histopathologic presentations. She had immediate resolution of abdominal symptoms after initiation of steroid treatment, but the gastritis and gastric ulcers improved slowly and lasted for months as shown in endoscopy. She was finally treated with extended steroid therapy without serious complications. We discuss the latest treatment options and our management strategies of the case.

Для цитирования: Liu W T, Li Y F, Hsieh T Y. Unusual severe gastritis and gastric ulcers caused by pembrolizumab.. Journal of postgraduate medicine. 2022. DOI: 10.4103/jpgm.jpgm_1132_20.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.